top of page

PMAC at ASCO 2025

  • carolinareduzzi
  • May 22
  • 1 min read

Updated: Nov 14

ree

Join us at ASCO 2025 and connect with our team during the poster sessions. We look forward to engaging discussions and sharing insights on advancing breast cancer care.


Poster Session

📍 June 2, 2025 | 9:00 AM – 12:00 PM


Breast Cancer — Local/Regional/Adjuvant

  • Poster Board 153: Cadence of circulating tumor DNA (ctDNA) testing for molecular surveillance in early-stage breast cancer (eBC)

    Presenter: Marla Lipsyc-Sharf


Breast Cancer — Metastatic

  • Poster Board 51: Molecular and prognostic convergence of HR+/HER2– metastatic breast cancer (MBC) to a TNBC-like profile: insights from circulating tumor DNA (ctDNA)-based genomic analysis across treatment lines

    Presenter: Lorenzo Foffano


  • Poster Board 25: Differences in genomic profiles, targeted treatment use, and overall survival in patients with metastatic breast cancer by Area Deprivation Index

    Presenter: Emily Podany

PMAC_logo_panna_rosso.png

Stay connected with us and join our mission to revolutionize cancer care.

  • Linkedin

© 2025 by Precision Medicine Action for Cancer. 

 

Precision Medicine Action for Cancer (PMAC) is a 501(c)(3) tax-exempt nonprofit organization.
Tax ID : EIN 33-4611004

bottom of page